BR9808290A - Composto, composição farmacêutica, processo de tratar infecções bacterianas em seres humanos e animais, uso de um composto, e, processo para sua preparação - Google Patents

Composto, composição farmacêutica, processo de tratar infecções bacterianas em seres humanos e animais, uso de um composto, e, processo para sua preparação

Info

Publication number
BR9808290A
BR9808290A BR9808290-6A BR9808290A BR9808290A BR 9808290 A BR9808290 A BR 9808290A BR 9808290 A BR9808290 A BR 9808290A BR 9808290 A BR9808290 A BR 9808290A
Authority
BR
Brazil
Prior art keywords
compound
preparation
animals
pharmaceutical composition
bacterial infections
Prior art date
Application number
BR9808290-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Ae Ri Kim
Jin Hwa Lee
Ki Sook Park
Jong Ryoo Choi
Tae Hee Lee
Jay Hyok Chang
Do Hyun Nam
Hoon Choi
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of BR9808290A publication Critical patent/BR9808290A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9808290-6A 1997-03-21 1998-03-20 Composto, composição farmacêutica, processo de tratar infecções bacterianas em seres humanos e animais, uso de um composto, e, processo para sua preparação BR9808290A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19970009840 1997-03-21
PCT/KR1998/000051 WO1998042705A1 (en) 1997-03-21 1998-03-20 Salt of naphthyridine carboxylic acid derivative

Publications (1)

Publication Number Publication Date
BR9808290A true BR9808290A (pt) 2000-05-16

Family

ID=19500439

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9808290-6A BR9808290A (pt) 1997-03-21 1998-03-20 Composto, composição farmacêutica, processo de tratar infecções bacterianas em seres humanos e animais, uso de um composto, e, processo para sua preparação

Country Status (38)

Country Link
US (9) US7700617B2 (enEXAMPLES)
EP (2) EP0981527B1 (enEXAMPLES)
JP (3) JP3759962B2 (enEXAMPLES)
KR (1) KR100266499B1 (enEXAMPLES)
CN (1) CN1131229C (enEXAMPLES)
AP (1) AP1331A (enEXAMPLES)
AR (1) AR012125A1 (enEXAMPLES)
AT (2) ATE239724T1 (enEXAMPLES)
AU (1) AU726634B2 (enEXAMPLES)
BG (1) BG63972B1 (enEXAMPLES)
BR (1) BR9808290A (enEXAMPLES)
CA (1) CA2283671C (enEXAMPLES)
CZ (2) CZ288673B6 (enEXAMPLES)
DE (2) DE69814378T2 (enEXAMPLES)
DK (2) DK0981527T3 (enEXAMPLES)
DZ (1) DZ2448A1 (enEXAMPLES)
EA (1) EA001674B1 (enEXAMPLES)
ES (2) ES2198697T3 (enEXAMPLES)
HU (2) HU225412B1 (enEXAMPLES)
ID (1) ID22681A (enEXAMPLES)
IL (2) IL131812A0 (enEXAMPLES)
IN (1) IN188178B (enEXAMPLES)
IS (2) IS2093B (enEXAMPLES)
MA (1) MA24500A1 (enEXAMPLES)
MY (1) MY137653A (enEXAMPLES)
NO (1) NO312515B1 (enEXAMPLES)
NZ (1) NZ337748A (enEXAMPLES)
OA (1) OA11161A (enEXAMPLES)
PE (1) PE67999A1 (enEXAMPLES)
PL (1) PL191815B1 (enEXAMPLES)
PT (2) PT1179533E (enEXAMPLES)
SA (1) SA98181055B1 (enEXAMPLES)
SI (2) SI0981527T1 (enEXAMPLES)
SK (1) SK284107B6 (enEXAMPLES)
TR (1) TR199902313T2 (enEXAMPLES)
UA (1) UA56218C2 (enEXAMPLES)
WO (1) WO1998042705A1 (enEXAMPLES)
ZA (1) ZA982335B (enEXAMPLES)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
HUP0200494A2 (en) * 1999-03-19 2002-08-28 Knoll Gmbh Use of-n,n-dimethyl-1-[1-(4 chlorophenyl)cyclobutyl]-3-metilbutilamine for treatment of osteoarthritis
US6331550B1 (en) 1999-06-29 2001-12-18 Smithkline Beecham Corporation Methods of use of quinolone compounds against anaerobic pathogenic bacteria
US6262071B1 (en) 1999-06-29 2001-07-17 Smithkline Beecham Corporation Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria
US6803376B1 (en) 1999-06-29 2004-10-12 Smithkline Beecham Corporation Method of use of quinolone compounds against pneumococcal and haemophilus bacteria
CA2282066C (en) 1999-06-29 2010-09-07 Smithkline Beecham Corporation Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria
GB9920919D0 (en) * 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) * 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GR1003520B (el) * 1999-09-22 2001-01-22 Smithkline Beecham Plc Μεθοδος χρησης ενωσεων φλουοροκινολονης εναντια σε νοσοκομειακα αρνητικα κατα gramμ παθογενων βακτηριδιων
WO2001021176A1 (en) * 1999-09-22 2001-03-29 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against bacteria
JP2001097864A (ja) * 1999-09-24 2001-04-10 Smithkline Beecham Corp 呼吸管および尿路病原性細菌に対するフルオロキノリン化合物の使用方法
JP2001097863A (ja) * 1999-09-24 2001-04-10 Smithkline Beecham Corp 嫌気性病原菌に対するフルオロキノロン化合物の使用法
JP2001097891A (ja) * 1999-09-24 2001-04-10 Smithkline Beecham Corp 呼吸器系病原菌に対するフルオロキノロン化合物の使用法
GR1003521B (el) * 1999-09-23 2001-01-22 Smithkline Beecham Plc Μεθοδοι χρησεως ενωσεων φλουοροκινολονης εναντια κατα gram θετικων παθογονων βακτηριδιων
KR20010091379A (ko) * 2000-03-15 2001-10-23 성재갑 7-(4-아미노메틸-3-옥심)피롤리딘 치환체를 갖는 퀴놀린카르복실산 유도체의 신규 제조방법
ATE410225T1 (de) 2001-08-02 2008-10-15 Lg Life Sciences Ltd Verfahren zur herstellung von amino-geschützten 4-aminomethylene-pyrrolidin-3-on-derivaten, gemifloxacin und deren salze
DE60222298T2 (de) * 2001-11-30 2008-01-03 Lg Life Sciences Ltd. Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem beta-lactam-antibiotikum
KR100517638B1 (ko) * 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
WO2006134608A1 (en) * 2005-06-15 2006-12-21 Hetero Drugs Limited Gemifloxacin process and polymorphs
KR101364900B1 (ko) * 2006-03-07 2014-02-19 욱크하트 리미티드 벤조퀴놀리진-2-카르복실산의 프로드러그
WO2010001408A2 (en) * 2008-06-06 2010-01-07 Matrix Laboratories Ltd. Novel polymorphic forms of gemifloxacin mesylate
WO2010146594A1 (en) * 2009-06-16 2010-12-23 Hetero Research Foundation Novel polymorphs of gemifloxacin mesylate
EP2491921A1 (en) * 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Conservation of anhydrous form of gemifloxacin
PL2820016T3 (pl) * 2012-02-27 2018-01-31 Bristol Myers Squibb Co 4 - (2 - okso-2, 3 - dihydro - 1h- imidazo [4, 5 -b]pirydyn - 1 - ylo) piperydyno - 1 - karboksylan n- (5s, 6s, 9r) - 5 -amino- 6 - (2, 3 - difluorofenylo) -6, 7, 8, 9 - tetrahydro - 5h - cyklohepta [b]pirydyn-9 - ylu, sól hemisiarczanowa
CZ2016104A3 (cs) * 2016-02-24 2017-09-06 Zentiva, K.S. Krystalické modifikace solí methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}fenyl)amino](fenyl)methyliden}-2-oxo-2,3-dihydro-1H-indol-6-karboxylátu a způsoby jejich přípravy

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR223983A1 (es) 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
ES8304117A1 (es) 1981-06-11 1983-02-16 Warner Lambert Co "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
IN162769B (enEXAMPLES) 1984-11-13 1988-07-09 Kyorin Seiyaku Kk
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH01100165A (ja) 1987-10-13 1989-04-18 Shionogi & Co Ltd オキシムまたはヒドロキシアミン誘導体系抗菌剤
US4920120A (en) 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
US4931446A (en) * 1988-03-23 1990-06-05 Abbott Laboratories Antimicrobial for in-vitro diagnostic kits
US5286723A (en) * 1988-08-31 1994-02-15 Daiichi Seiyaku Co., Ltd. Spiro compound
CA1336090C (en) * 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
PL166381B1 (pl) 1989-08-16 1995-05-31 Pfizer Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL
US5276041A (en) 1991-11-08 1994-01-04 Kaken Pharmaceutical Co., Ltd. Oxime derivatives
WO1993025545A1 (en) 1992-06-09 1993-12-23 Korea Research Institute Of Chemical Technology Novel quinoline derivatives and processes for preparing the same
US5776944A (en) * 1994-06-16 1998-07-07 Lg Chemical Ltd. 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
EP0688772B1 (en) * 1994-06-16 1999-05-06 LG Chemical Limited Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituents and processes for their preparation
DE69531305T2 (de) 1994-10-20 2004-05-13 Wakunaga Seiyaku K.K. Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten
WO1996023775A1 (fr) 1995-01-30 1996-08-08 Wakunaga Seiyaku Kabushiki Kaisha Nouveaux derives d'acide pyridonecarboxylique ou de ses sels et agent antibacterien contenant ces derives en tant qu'ingredient actif
CA2223404C (en) 1995-06-06 2001-01-16 Thomas A. Morris Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt
US20020032216A1 (en) * 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
KR100286874B1 (ko) * 1998-03-04 2001-04-16 성재갑 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process

Also Published As

Publication number Publication date
US20170253588A1 (en) 2017-09-07
CZ288715B6 (cs) 2001-08-15
NO312515B1 (no) 2002-05-21
SA98181055B1 (ar) 2006-10-11
AP9901649A0 (en) 1999-09-30
BG63972B1 (bg) 2003-08-29
NZ337748A (en) 2001-03-30
EA001674B1 (ru) 2001-06-25
IS2093B (is) 2006-04-12
MY137653A (en) 2009-02-27
EP1179533B1 (en) 2004-01-14
ES2198697T3 (es) 2004-02-01
CZ288673B6 (cs) 2001-08-15
IL131812A (en) 2006-04-10
AR012125A1 (es) 2000-09-27
EP0981527A1 (en) 2000-03-01
US7700617B2 (en) 2010-04-20
ZA982335B (en) 1999-11-23
CN1131229C (zh) 2003-12-17
TR199902313T2 (xx) 1999-12-21
US20130065917A1 (en) 2013-03-14
SI0981527T1 (en) 2003-10-31
JP2004002413A (ja) 2004-01-08
AP1331A (en) 2004-11-26
HU227536B1 (en) 2011-08-29
HUP0000728A3 (en) 2002-12-28
KR100266499B1 (ko) 2000-12-01
JP3759962B2 (ja) 2006-03-29
NO994595D0 (no) 1999-09-21
ES2213669T3 (es) 2004-09-01
UA56218C2 (uk) 2003-05-15
HUP0600401A3 (en) 2010-05-28
US20140187576A1 (en) 2014-07-03
IS2095B (is) 2006-04-12
CZ328299A3 (cs) 2000-02-16
JP2009051851A (ja) 2009-03-12
WO1998042705A1 (en) 1998-10-01
DE69814378T2 (de) 2004-02-26
AU726634B2 (en) 2000-11-16
KR19980080504A (ko) 1998-11-25
US20150291585A1 (en) 2015-10-15
EP0981527B1 (en) 2003-05-07
BG103750A (en) 2000-06-30
DZ2448A1 (fr) 2003-01-11
US20110312987A1 (en) 2011-12-22
NO994595L (no) 1999-09-21
ATE257836T1 (de) 2004-01-15
DE69814378D1 (de) 2003-06-12
DE69821147T2 (de) 2004-11-11
EP1179533A2 (en) 2002-02-13
CA2283671C (en) 2003-09-16
MA24500A1 (fr) 1998-10-01
JP2000510484A (ja) 2000-08-15
EA199900855A1 (ru) 2000-04-24
PT1179533E (pt) 2004-05-31
PL335812A1 (en) 2000-05-22
PL191815B1 (pl) 2006-07-31
CA2283671A1 (en) 1998-10-01
OA11161A (en) 2003-04-25
DK1179533T3 (da) 2004-05-03
HK1026698A1 (en) 2000-12-22
IN188178B (enEXAMPLES) 2002-08-31
AU6636698A (en) 1998-10-20
CN1251101A (zh) 2000-04-19
US20160264569A1 (en) 2016-09-15
ID22681A (id) 1999-12-09
IS5181A (is) 1999-09-14
US20100240694A1 (en) 2010-09-23
SI1179533T1 (en) 2004-04-30
EP1179533A3 (en) 2002-03-20
US20090182006A1 (en) 2009-07-16
DK0981527T3 (da) 2003-09-01
ATE239724T1 (de) 2003-05-15
US20080039488A1 (en) 2008-02-14
SK284107B6 (sk) 2004-09-08
SK123699A3 (en) 2000-08-14
IS7952A (is) 2005-07-21
DE69821147D1 (de) 2004-02-19
PE67999A1 (es) 1999-09-30
JP4781614B2 (ja) 2011-09-28
HUP0000728A2 (hu) 2000-09-28
HU225412B1 (en) 2006-11-28
HU0600401D0 (en) 2006-07-28
PT981527E (pt) 2003-09-30
IL131812A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
BR9808290A (pt) Composto, composição farmacêutica, processo de tratar infecções bacterianas em seres humanos e animais, uso de um composto, e, processo para sua preparação
BR9507502A (pt) Formulação de tablete processo de tratamento de infecções bacteriais em seres humanos ou em animais processo para preparação de uma formulação de tablete uso de uma formulação de tablete e processo de tratamento de uma infeção bacterial em um paciente humano
UY25792A1 (es) Preparado farmacéutico de moxifloxacina.
BR9510423A (pt) Formulação lipossomal multilamelar de baixa rigidez processo de tratamento ou de profilaxia de uma infecção bacteriana em um animal e de uma variante mucoìde da mesma, uso da formulação lipossomal antibacteriana
NO20042271L (no) Formuleringer som inneholder en cefalosporinforbindelse og deres anvendelse for behandling av bakterielle infeksjoner i katter og hunder
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
BRPI9915480B8 (pt) azalídeos de 13 membros, composições farmacêuticas compreendendo os mesmos, método para sua preparação bem como seus usos.
IE863104L (en) Quinolone derivatives
BR9813319A (pt) Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto
BR0111911A (pt) Preparados de ação prolongada de antibióticos de quinolona e processos para a sua preparação
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
IL109534A0 (en) Pour-on formulations containing polymeric material, glycols and glycerides and a process for their preparation
BR0011778A (pt) Tienopirimidinas
BR9710376A (pt) Composto antiviral uso do mesmo composi-Æo farmac-utica e processo para tratamento antiviral profil tico ou terap-utico de um animal humano ou nÆo humano
BR0013781A (pt) Pirazolo [4,3-d]pirimidinas
BR0009101A (pt) 9a-azalidas com atividade antibacteriana
BR9713044A (pt) Composto, uso de um composto, processo para sua preparação,e, formulação farmacêutica.
BR0111055A (pt) Formulação farmacêutica, e, processo para a preparação e uso da mesma
DK351484A (da) Pyrazolo(3,4,5-kl)acridinforbindelser, deres fremstilling og anvendelse
BR9709930A (pt) Composto composição farmacêutica uso de um composto e processos para tratamento de um indivíduo humano ou animal e para preparação de um composto
BR9808305A (pt) Forma hidratada cristalina, processo para a preparação da forma hidratada cristalina, composição farmacêutica, processo de tratamento de um mamìfero, e, processo de tratamento ou de prevenção de dor.
AR007983A1 (es) Formulacion
ZA873970B (en) Pharmaceutical formulation for the treatment of bacterial infections
PT89582A (pt) Processo para a preparacao de antibioticos beta-lactamicos uteis como medicamentos
MX9805962A (es) Pirido (3,2,1-ij)-1,3,4-benzoxadiazina.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: LG CHEM INVESTMENT LTD. (KR)

Free format text: ALTERADO DE: LG CHEMICAL LTD.

B25A Requested transfer of rights approved

Owner name: LG LIFE SCIENCES LTD. (KR)

Free format text: TRANSFERIDO DE: LG CHEM INVESTMENT LTD.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADO DE INT.CL: C07D 471/04; A61K 31/44; A61P 31/04

Ipc: C07D 471/04 (2008.01), A61K 31/44 (2008.01), A61P

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIDO O PEDIDO COM BASE NOS ARTIGOS 8O, 11 E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]